Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism-Reference-Cited by-同舟云学术

Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism

Published:2013-04-12 Issue:3 Volume:18 Page:143-147
ISSN:1362-5187
Container-title:The European Journal of Contraception & Reproductive Health Care
language:en
Short-container-title:The European Journal of Contraception & Reproductive Health Care

Author:

Bitzer Johannes,Amy Jean-Jacques,Beerthuizen Rob,Birkhäuser Martin,Bombas Teresa,Creinin Mitchell,Darney Philip D,Vicente Lisa Ferreira,Gemzell-Danielsson Kristina,Imthurn Bruno,Jensen Jeffrey T,Kaunitz Andrew M,Kubba Ali,Lech Medard M,Mansour Diana,Merki Gabriele,Rabe Thomas,Sedlecki Katarina,Serfaty David,Seydoux Jacques,Shulman Lee P,Sitruk-Ware Regine,Skouby Sven O,Szarewski Anne,Trussell James,Westhoff Carolyn

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Obstetrics and Gynaecology,Reproductive Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/13625187.2013.792637

Reference27 articles.

1. Hormonal contraception and risk of venous thromboembolism: national follow-up study

2. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

3. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data

4. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database

5. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Directive clinique n° 444 : Hirsutisme : Évaluation et traitement;Journal of Obstetrics and Gynaecology Canada;2023-12

2. Guideline No. 444: Hirsutism: Evaluation and Treatment;Journal of Obstetrics and Gynaecology Canada;2023-12

3. Harms of third- and fourth-generation combined oral contraceptives in premenopausal women: A systematic review and meta-analysis;Journal of Investigative Medicine;2023-07-06

4. Indicaciones de la drospirenona más allá de la anticoncepción.;Revista Ciencias Biomédicas;2021-04-15

5. Antiandrogens and Androgen Inhibitors;Comprehensive Dermatologic Drug Therapy;2021